Financhill
Back

Agios Pharmaceuticals Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.
Sell
48

AGIO
Agios Pharmaceuticals

Last Price:
34.54
Seasonality Move:
2.19%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Agios Pharmaceuticals Price Quote

$34.54

Agios Pharmaceuticals Key Stats

Sell
48
Agios Pharmaceuticals (AGIO) is a Sell

Day range:
$33.63 - $35.48
52-week range:
$19.80 - $35.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
71.66
P/B ratio:
2.39%

Volume:
807.9K
Avg. volume:
650.8K
1-year change:
51.03%
Market cap:
$1.9B
Revenue:
$26.8M
EPS:
$-6.34

How Much Does Agios Pharmaceuticals Make?

Is Agios Pharmaceuticals Growing As A Company?

  • What Is Agios Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.65%
  • What Is Agios Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Agios Pharmaceuticals Stock Price Performance

What Is Agios Pharmaceuticals 52-Week High & Low?

Agios Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Agios Pharmaceuticals?

Is Agios Pharmaceuticals Cash Flow Positive?

  • What Is AGIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$296.1M
  • What Is Agios Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.4M
  • What Is Agios Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $239.6M

Agios Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AGIO return on invested capital is -36.68%
  • What Is Agios Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -32.48%
  • What Is AGIO Return On Equity?
    ROE is a measure of profitability and is -36.68%

Agios Pharmaceuticals Earnings Date & Stock Price

Agios Pharmaceuticals Competitors

Agios Pharmaceuticals Dividend Yield

Data Unavailable

Agios Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.95%
Revenue: 64.8% -2.19%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 41.67
Upside from Last Price: 20.63%

Major Shareholders

  • How many AGIO shares are owned by institutional investors?
    89.3M AGIO shares are owned by institutional investors
  • How many AGIO shares are owned by insiders?
    1.2M AGIO shares are owned by insiders